Real-World Outcomes of Sequential BCMA-directed therapies in Relapsed Refractory Multiple Myeloma After Belantamab Exposure
Clinical Lymphoma Myeloma and Leukemia · 2025
DOI: 10.1016/j.clml.2025.06.015 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2025. Verfasst von Prerna Mewawalla und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Cellular Therapy, Allegheny Health Network, Pittsburgh, PA. Hauptthemen laut MEDLINE: Multiple Myeloma, B-Cell Maturation Antigen, Antibodies, Bispecific. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology and Cellular Therapy, Allegheny Health Network, Pittsburgh, PA.
- Allegheny-Singer Research Institute, Allegheny Health Network, Pittsburgh, PA.
- Division of Hematology, Oncology, and Blood and Marrow Transplantation, Holden Comprehensive Cancer Center, University of Iowa Hospital and Clinics, Iowa City, IA.
- Department of Hematology-Oncology, Medical University of South Carolina, Charleston, SC.
- University of South Alabama Mitchell Cancer Institute, Mobile, AL.
- Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Kansas City, MO.
Zitieren
APA
Mewawalla, P., Dileo, R., Yin, Y., Strouse, C., Shaikh, H., Davis, J. A., Alkharabsheh, O., Rashid, A., Ahmed, N., Abdallah, A. O., & Hashmi, H. (2025). Real-World Outcomes of Sequential BCMA-directed therapies in Relapsed Refractory Multiple Myeloma After Belantamab Exposure. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2025.06.015
Vancouver
Mewawalla P, Dileo R, Yin Y, Strouse C, Shaikh H, Davis JA, et al. Real-World Outcomes of Sequential BCMA-directed therapies in Relapsed Refractory Multiple Myeloma After Belantamab Exposure. Clinical Lymphoma Myeloma and Leukemia. 2025. doi:10.1016/j.clml.2025.06.015
BibTeX
@article{Mewawalla2025,
author = {Mewawalla, Prerna and Dileo, Rachel and Yin, Yue and Strouse, Christopher and Shaikh, Hira and Davis, James A and Alkharabsheh, Omar and Rashid, Aliya and Ahmed, Nausheen and Abdallah, Al-Ola and Hashmi, Hamza},
title = {Real-World Outcomes of Sequential BCMA-directed therapies in Relapsed Refractory Multiple Myeloma After Belantamab Exposure},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2025},
doi = {10.1016/j.clml.2025.06.015}
}
EUVIMED